Glenview Capital Management - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
Glenview Capital Management ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q1 2022$18,770,000
-13.7%
158,301
+0.3%
0.38%
-18.1%
Q4 2021$21,751,000
+36.9%
157,835
+38.0%
0.46%
+61.1%
Q3 2021$15,884,000
-63.2%
114,345
-74.3%
0.29%
-59.7%
Q2 2021$43,172,000
+37.7%
444,701
-3.0%
0.71%
+34.5%
Q1 2021$31,345,000
+396.8%
458,600
+372.6%
0.53%
+168.2%
Q3 2020$6,309,000
-28.3%
97,047
-19.4%
0.20%
-18.5%
Q2 2020$8,797,000120,3320.24%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
UBS OCONNOR LLC 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders